Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney

Molecular Pharmacology

Volumn 80, Issue 1, 2011, Pages 147-154

  Sweeney, Derina E ^a   Vallon, Volker ^a,b,e   Rieg, Timo ^a,e   Wu, Wei ^a   Gallegos, Thomas F ^c   Nigam, Sanjay K ^a,c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b San Diego   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; INULIN; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3;

4 AMINOHIPPURIC ACID CLEARANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG TRANSPORT; EMBRYO DEVELOPMENT; IN VIVO STUDY; INULIN CLEARANCE; KIDNEY FUNCTION; MICROARRAY ANALYSIS; NEPHRON; NEWBORN; NONHUMAN; PERINATAL DEVELOPMENT; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CARRIER PROTEINS; HUMANS; INFANT, NEWBORN; KIDNEY; MICE; MICE, KNOCKOUT; PHARMACEUTICAL PREPARATIONS; RATS; RNA, MESSENGER;

EID: 79959313678     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.070680     Document Type: Article

References (40)

1. Ahn SY and Nigam SK (2009) Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis. Mol Pharmacol 76:481-490.
2. Blackburn ST (2007) Pituitary, adrenal, and thyroid function, in Maternal, Fetal & Neonatal Physiology: a Clinical Perspective, p. 669-699, Saunders, St. Louis, MO.
3. Bräunlich H (1984) Postnatal development of kidney function in rats receiving thyroid hormones. Exp Clin Endocrinol 83:243-250.
4. Brunskill EW, Aronow BJ, Georgas K, Rumballe B, Valerius MT, Aronow J, Kaimal V, Jegga AG, Yu J, Grimmond S, et al. (2008) Atlas of gene expression in the developing kidney at microanatomic resolution. Dev Cell 15:781-791.
5. Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, and Klaassen CD (2002) Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 301:145-151. (Pubitemid 34250290)
6. Buist SC and Klaassen CD (2004) Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. Drug Metab Dispos 32:620-625. (Pubitemid 38668154)
7. Burckhardt BC and Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146:95-158.
8. Challis JRG, Matthews SG, Gibb W, and Lye SJ (2000) Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21:514-550.
9. Chappell K and Newman C (2004) Potential tenfold drug overdoses on a neonatal unit. Arch Dis Child Fetal Neonatal Ed 89:F483-F484. (Pubitemid 39472313)
10. Dickinson H, Walker DW, Cullen-McEwen L, Wintour EM, and Moritz K (2005) The spiny mouse (Acomys cahirinus) completes nephrogenesis before birth. Am J Physiol Renal Physiol 289:F273-F279. (Pubitemid 41003656)
11. Eder K and Ringseis R (2010) The role of peroxisome proliferator- activated receptor alpha in transcriptional regulation of novel organic cation transporters. Eur J Pharmacol 628:1-5.
12. Enomoto A, Takeda M, Shimoda M, Narikawa S, Kobayashi Y, Kobayashi Y, Yamamoto T, Sekine T, Cha SH, Niwa T, et al. (2002) Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther 301:797-802. (Pubitemid 34595067)
13. Eraly SA, Vallon V, Vaughn DA, Gangoiti JA, Richter K, Nagle M, Monte JC, Rieg T, Truong DM, Long JM, et al. (2006) Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J Biol Chem 281:5072-5083. (Pubitemid 43847773)
14. Evan AP, Gattone VH 2nd, and Schwartz GJ (1983) Development of solute transport in rabbit proximal tubule. II. Morphologic segmentation. Am J Physiol 245:F391-F407. (Pubitemid 13015708)
15. Fleck C, Hilger R, Jurkutat S, Karge E, Merkel U, Schimske A, and Schubert J (2002) Ex vivo stimulation of renal transport of the cytostatic drugs methotrexate, cisplatin, topotecan (Hycamtin) and raltitrexed (Tomudex) by dexamethasone, T3 and EGF in intact human and rat kidney tissue and in human renal cell carcinoma. Urol Res 30:256-262.
16. Freemark M (1999) The fetal adrenal and the maturation of the growth hormone and prolactin axes. Endocrinology 140:1963-1965.
17. He L, Vasiliou K, and Nebert DW (2009) Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics 3:195-206.
18. Holtbäck U and Aperia AC (2003) Molecular determinants of sodium and water balance during early human development. Semin Neonatol 8:291-299. (Pubitemid 36992824)
19. Hook JB and Bailie MD (1979) Perinatal renal pharmacology. Annu Rev Pharmacol Toxicol 19:491-509. (Pubitemid 9156588)
20. Hwang JS, Park EY, Kim WY, Yang CW, and Kim J (2010) Expression of OAT1 and OAT3 in differentiating proximal tubules of the mouse kidney. Histol Histopathol 25:33-44.
21. International Transporter Consortium, Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, et al. (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9:215-236.
22. Kojima R, Sekine T, Kawachi M, Cha SH, Suzuki Y, and Endou H (2002) Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am Soc Nephrol 13:848-857. (Pubitemid 34274080)
23. Kok T, Wolters H, Bloks VW, Havinga R, Jansen PL, Staels B, and Kuipers F (2003) Induction of hepatic ABC transporter expression is part of the PPARalphamediated fasting response in the mouse. Gastroenterology 124:160-171. (Pubitemid 36055349)
24. Ljubojevic M, Herak-Kramberger CM, Hagos Y, Bahn A, Endou H, Burckhardt G, and Sabolic I (2004) Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol 287:F124-F138. (Pubitemid 38780592)
25. Nagle MA, Truong DM, Dnyanmote AV, Ahn SY, Eraly SA, Wu W, and Nigam SK (2011) Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling. J Biol Chem 286:243-251.
26. Nigam SK, Bush KT, and Bhatnagar V (2007) Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nat Clin Pract Nephrol 3:443-448. (Pubitemid 47123587)
27. Pavlova A, Sakurai H, Leclercq B, Beier DR, Yu AS, and Nigam SK (2000) Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. Am J Physiol Renal Physiol 278:F635-F643. (Pubitemid 30215242)
28. Rosines E, Sampogna RV, Johkura K, Vaughn DA, Choi Y, Sakurai H, Shah MM, and Nigam SK (2007) Staged in vitro reconstitution and implantation of engineered rat kidney tissue. Proc Natl Acad Sci USA 104:20938-20943.
29. Sekine T and Endou H (2009) Children's toxicology from bench to bed - Drug-induced renal injury (3): Drug transporters and toxic nephropathy in childhood. J Toxicol Sci 34:SP259-SP265.
30. Sweet DH, Eraly SA, Vaughn DA, Bush KT, and Nigam SK (2006) Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models. Kidney Int 69:837-845.
31. Sweet DH, Miller DS, Pritchard JB, Fujiwara Y, Beier DR, and Nigam SK (2002) Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem 277:26934-26943. (Pubitemid 34951703)
32. Truong DM, Kaler G, Khandelwal A, Swaan PW, and Nigam SK (2008) Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination. J Biol Chem 283:8654-63.
33. Tsigelny IF, Kouznetsova VL, Sweeney DE, Wu W, Bush KT, and Nigam SK (2008) Analysis of metagene portraits reveals distinct transitions during kidney organogenesis. Sci Signal 1:ra16.
34. Vallon V, Eraly SA, Wikoff WR, Rieg T, Kaler G, Truong DM, Ahn SY, Mahapatra NR, Mahata SK, Gangoiti JA, et al. (2008) Organic anion transporter 3 contributes to the regulation of blood pressure. J Am Soc Nephrol 19:1732-1740.
35. Vallon V, Rieg T, Ahn SY, Wu W, Eraly SA, and Nigam SK (2008) Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am J Physiol Renal Physiol 294:F867-F873.
36. Vallon V, Schroth J, Satriano J, Blantz RC, Thomson SC, and Rieg T (2009) Adenosine A(1) receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus. Nephron Physiol 111:p30-38.
37. Vanwert AL, Bailey RM, and Sweet DH (2007) Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. Am J Physiol Renal Physiol 293:F1332-F1341. (Pubitemid 47583969)
38. Warner A (1986) Drug use in the neonate: interrelationships of pharmacokinetics, toxicity, and biochemical maturity. Clin Chem 32:721-727.
39. Wu W, Baker ME, Eraly SA, Bush KT, and Nigam SK (2009) Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species-specific amplification of subsets of family members. Physiol Genomics 38:116-124.
40. Wu W, Dnyanmote AV, and Nigam SK (2011) Remote Communication through Solute Carriers and ATP Binding Cassette Drug Transporter Pathways: An Update on the Remote Sensing and Signaling Hypothesis. Mol Pharmacol 79:795-805.